ITI Pharma and Healthcare Fund Direct Reinvestment Inc Dist cum Cap Wdrl

ITI Pharma and Healthcare Fund Direct Reinvestment Inc Dist cum Cap Wdrl

Equity

ITI Mutual Fund

Sector - Healthcare

Get the latest NAV of ITI Pharma and Healthcare Fund Direct Reinvestment Inc Dist cum Cap Wdrl. View historical returns compared to its benchmark and category average. Know which stocks and sectors the fund is investing in. Get an estimate of returns from the SIP and lump sum returns calculator. View detailed holding analysis and peer comparison. Get INDmoney ranking of the fund.

₹17.78

NAV as on 12 Sep 2025

16.18%/per year

Since Inception

Absolute Gain%

▲▼

ITI Pharma and Healthcare Fund Direct Reinvestment Inc Dist cum Cap Wdrl Performance vs. Nifty 500

Fund returns vs Benchmark returns vs Category Average returns as on (12-Sep-25)

The fund has outperformed the benchmark (Nifty 500) over 1Y, 3Y, but underperformed over 5Y.

Period
1M
3M
6M
1Y
3Y
5Y
This Fund
1.92%
1.42%
11.36%
-2.13%
23.61%
--
Nifty 500
2.25%
1.24%
14.94%
-3.08%
14.05%
19.56%
Sector - Healthcare Avg
2.19%
2.94%
13.42%
0.24%
23.5%
19.33%
Best in Sector - Healthcare
4.98%
5.81%
17.3%
10.19%
29.51%
22.91%
Worst in Sector - Healthcare
0.8%
0.53%
9.96%
-9.73%
21.72%
16.4%

Peer comparison

Fund Name
INDmoney Rank
AUM (in Crs.)
Expense Ratio
1Y Returns
3Y Returns
3Y Alpha
3Y Beta
3Y Sharpe
3Y Sortino
3Y Info Ratio
ITI Pharma and Healthcare Fund Direct Reinvestment Inc Dist cum Cap Wdrl
-
227Cr
0.47%
-2.13%
23.61%
1.70
0.90
0.98
1.65
0.11
ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund Dir Payout of Inc Dist cum Cap Wdrl Direct Growth
-
4,918Cr
1.08%
19.91%
23%
3.13
--
--
2.10
0.80
SBI Healthcare Opportunities Fund Payout Inc Dist cum Cap Wdrl Direct Growth
-
3,522Cr
0.89%
16.9%
23.6%
5.14
--
--
2.32
1.01
ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund Dir Reinvmt of Inc Dist cum Cap Wdrl Direct Growth
-
4,918Cr
1.08%
19.91%
23%
3.13
--
--
2.10
0.80
See all

ITI Pharma and Healthcare Fund Direct Reinvestment Inc Dist cum Cap Wdrl Returns Calculator

Calculate SIP and lumpsum returns based on historical performance

  • 1-time

  • SIP

Total Investment

0

Profit

Total Corpus

0

Absolute Return
▲
▼

ITI Pharma and Healthcare Fund Direct Reinvestment Inc Dist cum Cap Wdrl Asset Allocation

See fund asset allocation details as on (14-Aug-25)

Fund Distribution

as on (14-Aug-25)

Large cap
47.6%
Small cap
30.2%
Mid cap
20.1%
Large Cap allocation has gone up from 27.3% to 45.3%
Large Cap allocation has gone up from 27.3% to 45.3%
Small Cap allocation has gone up from 33.6% to 33.8%
Small Cap allocation has gone up from 33.6% to 33.8%
Mid Cap allocation has gone down from 35.2% to 19.6%
Mid Cap allocation has gone down from 35.2% to 19.6%
Cash allocation has gone down from 2.7% to 1.3%
Cash allocation has gone down from 2.7% to 1.3%

ITI Pharma and Healthcare Fund Direct Reinvestment Inc Dist cum Cap Wdrl Sector Allocation

See fund sector allocation details as on (14-Aug-25)

Sector Allocation

Health
96.9%
Basic Materials
2.3%
Industrial
0.8%

Top 3 Sectors in July were Health, Basic Materials & Industrial

Jul'25

Health

92%

Basic Materials

5%

Industrial

2%

Jun'25

Health

95%

Basic Materials

4%

Industrial

1%

ITI Pharma and Healthcare Fund Direct Reinvestment Inc Dist cum Cap Wdrl Holdings Details

as on (31-Aug-25)

Top Stocks bought last month
Fortis Healthcare Ltd's allocation increased from 2.62% to 3.51%
Fortis Healthcare Ltd's allocation increased from 2.62% to 3.51%
Torrent Pharmaceuticals Ltd's allocation increased from 4.03% to 4.58%
Torrent Pharmaceuticals Ltd's allocation increased from 4.03% to 4.58%
Apollo Hospitals Enterprise Ltd's allocation increased from 5.35% to 5.66%
Apollo Hospitals Enterprise Ltd's allocation increased from 5.35% to 5.66%
Top Stocks sold last month
Sun Pharmaceuticals Industries Ltd's allocation decreased from 11.99 % to 10.93 %
Sun Pharmaceuticals Industries Ltd's allocation decreased from 11.99 % to 10.93 %
Divi's Laboratories Ltd's allocation decreased from 9.03 % to 8.68 %
Divi's Laboratories Ltd's allocation decreased from 9.03 % to 8.68 %
Aurobindo Pharma Ltd's allocation decreased from 3.73 % to 3.66 %
Aurobindo Pharma Ltd's allocation decreased from 3.73 % to 3.66 %

ITI Pharma and Healthcare Fund Direct Reinvestment Inc Dist cum Cap Wdrl Overview

Get key fund statistics, minimum investment details, AUM, expense ratio, exit load, and tax treatment.

Expense ratio0.47%
Benchmark
Nifty Healthcare TR INR
AUM₹227 Cr
Inception Date11 November, 2021
Min Lumpsum/SIP₹5000/₹500
Exit Load
0.5%
Lock InNo Lock-in
TurnOver
63.9%
Risk
Risk meter
pointer
Very High Risk

About ITI Pharma and Healthcare Fund Direct Reinvestment Inc Dist cum Cap Wdrl

ITI Pharma and Healthcare Fund Direct Reinvestment Inc Dist cum Cap Wdrl is an equity fund. This fund was started on 11 November, 2021. The fund is managed by Dhimant Shah, Rohan Korde. The fund could potentially beat inflation in the long-run.

Key Parameters

  1. ITI Pharma and Healthcare Fund Direct Reinvestment Inc Dist cum Cap Wdrl has ₹227 Cr worth of assets under management (AUM) as on Aug 2025 and is more than category average.
  2. The fund has an expense ratio 0.5.

Returns

ITI Pharma and Healthcare Fund Direct Reinvestment Inc Dist cum Cap Wdrl has given a CAGR return of 16.18% since inception. Over the last 1 and 3 years the fund has given a CAGR return of -2.13% and 23.61% respectively.

Holdings

ITI Pharma and Healthcare Fund Direct Reinvestment Inc Dist cum Cap Wdrl has allocated its funds majorly in Cash Equivalent, Health, Basic Materials, Industrial, Financial Services. Its top holdings are Sun Pharmaceuticals Industries Ltd, Divi's Laboratories Ltd, Apollo Hospitals Enterprise Ltd, Max Healthcare Institute Ltd Ordinary Shares, Torrent Pharmaceuticals Ltd

Taxation

As it is a sector - healthcare mutual fund the taxation is as follows:
For short term (less than a year) capital gains will be taxed at 20%
For long term (more than 1 year) capital gains will be taxed at 12.5% without indexation benefit
Dividends will always be taxed at slab rate. Long term gains upto Rs 1 lakh are exempt capital gains tax.

Investment objective of ITI Pharma and Healthcare Fund Direct Reinvestment Inc Dist cum Cap Wdrl

The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare. However, there can be no assurance that the investment objective of the scheme would be achieved.

Minimum Investment and lockin period

Minimum investment for lump sum payment is INR 5000.00 and for SIP is INR 500.00. ITI Pharma and Healthcare Fund Direct Reinvestment Inc Dist cum Cap Wdrl has no lock in period.

Fund Manager

Dhimant Shah

Fund Manager of ITI Pharma and Healthcare Fund Direct Reinvestment Inc Dist cum Cap Wdrl, since 1 December 2022

Rohan Korde

Fund Manager of ITI Pharma and Healthcare Fund Direct Reinvestment Inc Dist cum Cap Wdrl, since 11 November 2021

Learn more about ITI Mutual Fund
Parameters
Jul'25
Jun'25
May'25
AUM
₹ 235.7 Cr
₹ 229.9 Cr
₹ 220.8 Cr
  • AUM of the fund stands at 235.7 Cr as of Jul'25
  • AUM increased by 5.8 Cr between Jul'25 and Jun'25

Frequently Asked Questions for ITI Pharma and Healthcare Fund Direct Reinvestment Inc Dist cum Cap Wdrl

How do I invest in ITI Pharma and Healthcare Fund Direct Reinvestment Inc Dist cum Cap Wdrl?

INDmoney makes it simple to invest in the ITI Pharma and Healthcare Fund Direct Reinvestment Inc Dist cum Cap Wdrl. To do so, follow the steps below:
  • Download the INDmoney app.
  • Search for ‘ITI Pharma and Healthcare Fund Direct Reinvestment Inc Dist cum Cap Wdrl’.
  • Select whether you want to invest in SIP or lump sum.
  • Enter the amount you wish to invest.
  • Set up payments via bank mandate or UPI.

What is the current NAV of ITI Pharma and Healthcare Fund Direct Reinvestment Inc Dist cum Cap Wdrl?

The NAV of the fund today is ₹17.78. NAV or Net Asset Value is the per unit price of a mutual fund. For example, if the NAV of a fund is ₹10, it means you can get 1000 units of that mutual fund at ₹10,000.

What is the return on the fund?

ITI Pharma and Healthcare Fund Direct Reinvestment Inc Dist cum Cap Wdrl fund has generated a return of -2.13% in 1 year, 23.61% in 3 years

Who is the fund manager of ITI Pharma and Healthcare Fund Direct Reinvestment Inc Dist cum Cap Wdrl?

The fund managers are Dhimant Shah, Rohan Korde.

What is the exit load of the fund?

The exit load is 0.5% if redeemed in 0-3 Months. Exit load is a fee levied for ‘exiting’ the fund earlier than a stipulated period, usually 1 year.

What is the expense ratio of the fund?

The expense ratio is 0.47%. The Expense Ratio is a fee charged for managing the fund. This includes commissions, administrative costs etc.

What is the AUM of the fund?

The AUM of the fund is ₹227 Cr. AUM stands for Assets Under Management. It refers to the total assets managed by the fund.

What are the top holdings of ITI Pharma and Healthcare Fund Direct Reinvestment Inc Dist cum Cap Wdrl?

The top 3 holdings of the fund are Sun Pharmaceuticals Industries Ltd(10.6%), Divi's Laboratories Ltd(8.38%), Apollo Hospitals Enterprise Ltd(5.96%)